Literature DB >> 21999585

Cytolytic replication of echoviruses in colon cancer cell lines.

Stina Israelsson1, Nina Jonsson, Maria Gullberg, A Michael Lindberg.   

Abstract

BACKGROUND: Colorectal cancer is one of the most common cancers in the world, killing nearly 50% of patients afflicted. Though progress is being made within surgery and other complementary treatments, there is still need for new and more effective treatments. Oncolytic virotherapy, meaning that a cancer is cured by viral infection, is a promising field for finding new and improved treatments. We have investigated the oncolytic potential of several low-pathogenic echoviruses with rare clinical occurrence. Echoviruses are members of the enterovirus genus within the family Picornaviridae.
METHODS: Six colon cancer cell lines (CaCo-2, HT29, LoVo, SW480, SW620 and T84) were infected by the human enterovirus B species echovirus 12, 15, 17, 26 and 29, and cytopathic effects as well as viral replication efficacy were investigated. Infectivity was also tested in spheroids grown from HT29 cells.
RESULTS: Echovirus 12, 17, 26 and 29 replicated efficiently in almost all cell lines and were considered highly cytolytic. The infectivity of these four viruses was further evaluated in artificial tumors (spheroids), where it was found that echovirus 12, 17 and 26 easily infected the spheroids.
CONCLUSIONS: We have found that echovirus 12, 17 and 26 have potential as oncolytic agents against colon cancer, by comparing the cytolytic capacity of five low-pathogenic echoviruses in six colon cancer cell lines and in artificial tumors.

Entities:  

Mesh:

Year:  2011        PMID: 21999585      PMCID: PMC3213228          DOI: 10.1186/1743-422X-8-473

Source DB:  PubMed          Journal:  Virol J        ISSN: 1743-422X            Impact factor:   4.099


  50 in total

1.  Antigenic purity and plaque properties of the prototype strains of ECHO virus types 7 to 11, and 17 and 18.

Authors:  R WIGAND; A B SABIN
Journal:  Arch Gesamte Virusforsch       Date:  1962

2.  OBSERVATIONS ON A GROUP OF VIRUSES (JV-5, JV-6 AND JV-10) COMPRISING A NEWLY RECOGNIZED ENTEROVIRUS SEROTYPE.

Authors:  L ROSEN; J KERN; J A BELL
Journal:  Am J Hyg       Date:  1964-01

3.  Isolation and characterization of prototype viruses ECHO-26, ECHO-27, Coxsackie B-6.

Authors:  W M HAMMON; D S YOHN; R A PAVIA
Journal:  Proc Soc Exp Biol Med       Date:  1960-01

4.  Problems raised by certain ECHO viruses in the attempted laboratory detection of poliomyelitis virus infection.

Authors:  W M HAMMON; E H LUDWIG; R A PAVIA; L W MCCLOSKEY; G E SATHER
Journal:  Ann N Y Acad Sci       Date:  1957-04-19       Impact factor: 5.691

5.  Biologic and serologic characteristics of ECHO viruses from West Virginia.

Authors:  R A ORMSBEE; J L MELNICK
Journal:  J Immunol       Date:  1957-11       Impact factor: 5.422

6.  Intestinal viral flora of healthy children demonstrable by monkey kidney tissue culture.

Authors:  M RAMOS-ALVAREZ; A B SABIN
Journal:  Am J Public Health Nations Health       Date:  1956-03

Review 7.  Development of transcriptionally regulated oncolytic adenoviruses.

Authors:  Derek Ko; Lynda Hawkins; De-Chao Yu
Journal:  Oncogene       Date:  2005-11-21       Impact factor: 9.867

Review 8.  Oncolytic adenoviruses - selective retargeting to tumor cells.

Authors:  J Michael Mathis; Mariam A Stoff-Khalili; David T Curiel
Journal:  Oncogene       Date:  2005-11-21       Impact factor: 9.867

9.  Enteroviruses in Tunisia: virological surveillance over 12 years (1992-2003).

Authors:  O Bahri; D Rezig; B Ben Nejma-Oueslati; A Ben Yahia; J Ben Sassi; N Hogga; A Sadraoui; H Triki
Journal:  J Med Microbiol       Date:  2005-01       Impact factor: 2.472

10.  Oncolysis of human ovarian cancers by echovirus type 1.

Authors:  Darren R Shafren; Dianne Sylvester; E Susanne Johansson; Ian G Campbell; Richard D Barry
Journal:  Int J Cancer       Date:  2005-06-10       Impact factor: 7.396

View more
  11 in total

1.  Improved replication efficiency of echovirus 5 after transfection of colon cancer cells using an authentic 5' RNA genome end methodology.

Authors:  S Israelsson; A Sävneby; J-O Ekström; N Jonsson; K Edman; A M Lindberg
Journal:  Invest New Drugs       Date:  2014-07-23       Impact factor: 3.850

Review 2.  Therapeutic Use of Native and Recombinant Enteroviruses.

Authors:  Jani Ylä-Pelto; Lav Tripathi; Petri Susi
Journal:  Viruses       Date:  2016-02-23       Impact factor: 5.048

Review 3.  The Double-Edged Sword Role of Viruses in Gastric Cancer.

Authors:  Paulina Niedźwiedzka-Rystwej; Ewelina Grywalska; Rafał Hrynkiewicz; Mikołaj Wołącewicz; Rafał Becht; Jacek Roliński
Journal:  Cancers (Basel)       Date:  2020-06-24       Impact factor: 6.639

4.  Oral poliovirus vaccine-induced programmed cell death involves both intrinsic and extrinsic pathways in human colorectal cancer cells.

Authors:  Sareh Zhand; Seyed Masoud Hosseini; Alijan Tabarraei; Mohsen Saeidi; Marie Saghaeian Jazi; Mohamad Reza Kalani; Abdolvahab Moradi
Journal:  Oncolytic Virother       Date:  2018-10-30

Review 5.  Three-dimensional tumor cell cultures employed in virotherapy research.

Authors:  Linus D Kloker; Can Yurttas; Ulrich M Lauer
Journal:  Oncolytic Virother       Date:  2018-09-05

Review 6.  Developing Picornaviruses for Cancer Therapy.

Authors:  Cormac McCarthy; Nadishka Jayawardena; Laura N Burga; Mihnea Bostina
Journal:  Cancers (Basel)       Date:  2019-05-16       Impact factor: 6.639

7.  Growth inhibition of different human colorectal cancer xenografts after a single intravenous injection of oncolytic vaccinia virus GLV-1h68.

Authors:  Klaas Ehrig; Mehmet O Kilinc; Nanhai G Chen; Jochen Stritzker; Lisa Buckel; Qian Zhang; Aladar A Szalay
Journal:  J Transl Med       Date:  2013-03-26       Impact factor: 5.531

8.  Viral persistence in colorectal cancer cells infected by Newcastle disease virus.

Authors:  Suet-Lin Chia; Khatijah Yusoff; Norazizah Shafee
Journal:  Virol J       Date:  2014-05-16       Impact factor: 4.099

9.  Effect of the oncolytic ECHO-7 virus Rigvir® on the viability of cell lines of human origin in vitro.

Authors:  Andra Tilgase; Liene Patetko; Ilze Blāķe; Anna Ramata-Stunda; Mārtiņš Borodušķis; Pēteris Alberts
Journal:  J Cancer       Date:  2018-02-28       Impact factor: 4.207

Review 10.  Spheroids and organoids as humanized 3D scaffold-free engineered tissues for SARS-CoV-2 viral infection and drug screening.

Authors:  Gabriela S Kronemberger; Fabiana A Carneiro; Danielle F Rezende; Leandra S Baptista
Journal:  Artif Organs       Date:  2021-01-10       Impact factor: 2.663

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.